99 Projects to Accelerate Discovery
The Cancer Research Society (CRS) is pleased to announce the recipients of its 2026 Operating Grants. Thanks to the unwavering support of its donors and the commitment of its partners, CRS is investing in 99 new research projects that will help advance cancer prevention, detection, treatment, and quality of life for people affected by cancer.
Selected through a rigorous evaluation process conducted by expert committees, the funded projects stand out for their scientific excellence, innovation, and potential impact.
This important milestone reflects the CRS’s commitment to supporting research excellence across Canada and empowering research teams to pursue the ideas that will drive tomorrow’s breakthroughs. Behind each selected project lies a shared ambition: to expand the boundaries of knowledge and accelerate progress against cancer.
Discover the 99 grant recipients and their promising research projects: here
A Collective Commitment to Advancing Cancer Research
This program represents a total investment of $13.9 million over two years, made possible by the generosity of donors and the contributions of valued partners.
CRS extends its sincere thanks to the CIHR – Institute of Cancer Research, la Vie en Rose, Ovarian Cancer Canada, Brain Canada Foundation, RBC Royal Bank, Michael Smith Health Research BC, iA Financial Group, the Pageau and Guilmette Family Fund, Challenge rose, and the WindsorEssex Community Foundation, through the Cancer Research Collaboration Fund, for their trust and support.
Congratulations to all 2026 grant recipients! Behind every project are passionate researchers exploring new possibilities in the hope of building a better future. CRS is proud to help turn these ambitions into meaningful advances for patients and their families.